# Data Retention When Subjects Withdraw from FDA-Regulated Clinical Trials:  Guidance for Sponsors, Clinical Investigators, and IRBs - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/data-retention-when-subjects-withdraw-from-fda-regulated-clinical-trials-guidance-for-sponsors-clinical-investigators-and-irbs/3358ed6a-403d-4aaa-b66c-941d2d2630ab

> FDA guidance document: Data Retention When Subjects Withdraw from FDA-Regulated Clinical Trials:  Guidance for Sponsors, Clinical Investigators, and IRBs. Issue date: October 01, 2008. Get complete insights and analysis.

---

## Details

- Title: Data Retention When Subjects Withdraw from FDA-Regulated Clinical Trials:  Guidance for Sponsors, Clinical Investigators, and IRBs
- Communication Type: Guidance Document
- Product Type: devices
- Office Name: Office of the Commissioner
- Office URL: /offices/office-of-the-commissioner/79483979-9582-427f-ac3d-46c715811424
- Issue Date: 2008-10-01
- Last Changed: 2021-07-21
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2008-D-0576">FDA-2008-D-0576</a>

## Related Documents

- [Role of HIV Drug Resistance Testing in Antiretroviral Drug Development](https://www.globalkeysolutions.net/guidances/guidance-document/role-of-hiv-drug-resistance-testing-in-antiretroviral-drug-development/b63afac3-86d1-45b1-bee0-b25944c92926)
- [180-Day Exclusivity When Multiple ANDAs Are Submitted on the Same Day](https://www.globalkeysolutions.net/guidances/guidance-document/180-day-exclusivity-when-multiple-andas-are-submitted-on-the-same-day/26a43ba4-c062-4358-b394-9623fa7f9f78)
- [Frequently Asked Questions - IRB Registration:  Guidance for Institutional Review Boards (IRBs)](https://www.globalkeysolutions.net/guidances/guidance-document/frequently-asked-questions-irb-registration-guidance-for-institutional-review-boards-irbs/7a3de4e3-164a-476e-983c-437126be73f7)